{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:51:49Z","timestamp":1793735509900,"version":"4.6.1"},"reference-count":49,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) and Multiple Sclerosis (MS) represent an emerging health problem on a global scale, as they are responsible for a significant contribution to the burden of disability in Western countries. Limited numbers of cerebrospinal fluid (CSF) diagnostic markers are available for each disease (amyloid and tau deposition markers for AD and oligoclonal bands for MS) representing mostly state markers that provide few, if any, clues about the severity of the clinical phenotype. \u03b1-CGRP is a neuropeptide implied in nociception, vasodilation, synaptic plasticity and immune functions. This neuropeptide is expressed in encephalic regions connected to memory, attention, autonomic and behavioral functions and is also expressed by spinal motor neurons. The present work confronted \u03b1-CGRP levels between 19 AD, 27 MS and 17 control subjects using an ELISA\/EIA assay. We measured higher CSF \u03b1-CGRP contents in control subjects with respect to AD, as shown in previous studies, as well as in MS patients in comparison to AD. The control subjects and MS patients did not significantly differ between each other. We did not observe a relationship between CSF protein content, albumin quotient and \u03b1-CGRP. We also describe, retrospectively, an association between higher CSF CGRP content and higher MRI overall lesion count in MS and between lower \u03b1-CGRP and worse attention and visuo-perceptual skills in AD. We speculate that \u03b1-CGRP could be differentially involved in both disabling diseases.<\/jats:p>","DOI":"10.3390\/biom12020199","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T20:44:33Z","timestamp":1643143473000},"page":"199","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cerebrospinal Fluid \u03b1-Calcitonin Gene-Related Peptide: A Comparison between Alzheimer\u2019s Disease and Multiple Sclerosis"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8676-2935","authenticated-orcid":false,"given":"Giulio","family":"Papiri","sequence":"first","affiliation":[{"name":"Neurology Clinic, Azienda Ospedaliero Universitaria, Ospedali Riuniti di Ancona, 60126 Torrette di Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2496-7932","authenticated-orcid":false,"given":"Arianna","family":"Vignini","sequence":"additional","affiliation":[{"name":"Section of Biochemistry, Department of Clinical Sciences, Biology and Physics, Universit\u00e0 Politecnica delle Marche, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Capriotti","sequence":"additional","affiliation":[{"name":"Anesthesiology and Intensive Care Unit, Ospedale Provinciale \u201cMadonna del Soccorso\u201d, 63074 San Benedetto del Tronto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Verdenelli","sequence":"additional","affiliation":[{"name":"Anesthesiology and Intensive Care Unit, Ospedale Provinciale \u201cMadonna del Soccorso\u201d, 63074 San Benedetto del Tronto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3038-854X","authenticated-orcid":false,"given":"Sonila","family":"Alia","sequence":"additional","affiliation":[{"name":"Section of Biochemistry, Department of Clinical Sciences, Biology and Physics, Universit\u00e0 Politecnica delle Marche, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0269-6331","authenticated-orcid":false,"given":"Alice","family":"Di Paolo","sequence":"additional","affiliation":[{"name":"Section of Biochemistry, Department of Clinical Sciences, Biology and Physics, Universit\u00e0 Politecnica delle Marche, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Fiori","sequence":"additional","affiliation":[{"name":"Neurology Clinic, Azienda Ospedaliero Universitaria, Ospedali Riuniti di Ancona, 60126 Torrette di Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Baldinelli","sequence":"additional","affiliation":[{"name":"Neurology Clinic, Azienda Ospedaliero Universitaria, Ospedali Riuniti di Ancona, 60126 Torrette di Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3545-7388","authenticated-orcid":false,"given":"Mauro","family":"Silvestrini","sequence":"additional","affiliation":[{"name":"Neurology Clinic, Azienda Ospedaliero Universitaria, Ospedali Riuniti di Ancona, 60126 Torrette di Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3802-2320","authenticated-orcid":false,"given":"Simona","family":"Luzzi","sequence":"additional","affiliation":[{"name":"Neurology Clinic, Azienda Ospedaliero Universitaria, Ospedali Riuniti di Ancona, 60126 Torrette di Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"ref_1","unstructured":"WHO (2017). Global Action Plan on the Public Health Response to Dementia 2017\u20132025, WHO."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The Cellular Phase of Alzheimer\u2019s Disease","volume":"164","author":"Karran","year":"2016","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00702-012-0797-8","article-title":"Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer\u2019s disease","volume":"119","author":"Daborg","year":"2012","journal-title":"J. Neural Transm."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00002093-199806000-00008","article-title":"Activation of the Contact System in Cerebrospinal Fluid of Patients with Alzheimer Disease","volume":"12","author":"Bergamaschini","year":"1998","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple Sclerosis: Mechanisms and Immunotherapy","volume":"97","author":"Kaskow","year":"2018","journal-title":"Neuron"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(16)31320-4","article-title":"Progressive multiple sclerosis: Prospects for disease therapy, repair, and restoration of function","volume":"389","author":"Ontaneda","year":"2016","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp-2016-313300","article-title":"Neurodegeneration in multiple sclerosis and neuromyelitis optica","volume":"88","author":"Kawachi","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-200868","article-title":"The Role of Amyloid-\u03b2 in White Matter Damage: Possible Common Pathogenetic Mechanisms in Neurodegenerative and Demyelinating Diseases","volume":"78","author":"Pietroboni","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1474-4422(18)30498-8","article-title":"A global perspective on the burden of multiple sclerosis","volume":"18","author":"Stenager","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3233\/JAD-2011-111349","article-title":"Performance of A\u03b21-40, A\u03b21-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment","volume":"29","author":"Parnetti","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"a029058","DOI":"10.1101\/cshperspect.a029058","article-title":"Biomarkers in Multiple Sclerosis","volume":"9","author":"Paul","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin Gene-Related Peptide: Physiology and Pathophysiology","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1474-4422(17)30435-0","article-title":"The pathophysiology of migraine: Implications for clinical management","volume":"17","author":"Charles","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000502471","article-title":"The Presence of Calcitonin Gene-Related Peptide and Its Receptors in Rat, Pig and Human Brain: Species Differences in Calcitonin Gene-Related Peptide Pharmacology","volume":"104","author":"Warfvinge","year":"2019","journal-title":"Pharmacology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/00001756-199307000-00003","article-title":"The peptidergic motoneurone","volume":"4","author":"Arvidsson","year":"1993","journal-title":"Neuroreport"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/(SICI)1097-4547(19961101)46:3<316::AID-JNR4>3.0.CO;2-N","article-title":"The psychotomimetic drugs d-amphetamine and phencyclidine release calcitonin gene-related peptide in the limbic forebrain of the rat","volume":"46","author":"Hertel","year":"1996","journal-title":"J. Neurosci Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0031-9384(95)00066-R","article-title":"Effects of CGRP on active avoidance behavior in rats","volume":"58","author":"Telegdy","year":"1995","journal-title":"Physiol. Behav."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/head.13591","article-title":"CGRP and Brain Functioning: Cautions for Migraine Treatment","volume":"59","author":"Borkum","year":"2019","journal-title":"Headache: J. Head Face Pain"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/neu.2018.31","article-title":"CGRP in a gene\u2013environment interaction model for depression: Effects of antidepressant treatment","volume":"31","author":"Angelucci","year":"2018","journal-title":"Acta Neuropsychiatr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"srep12559","DOI":"10.1038\/srep12559","article-title":"Calcitonin gene-related peptide pre-administration acts as a novel antidepressant in stressed mice","volume":"5","author":"Ogawa","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4049\/jimmunol.179.1.607","article-title":"Negative Regulation of TLR Responses by the Neuropeptide CGRP Is Mediated by the Transcriptional Repressor ICER","volume":"179","author":"Harzenetter","year":"2007","journal-title":"J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2990.2004.00559.x","article-title":"Spinal motoneurone distress during experimental allergic encephalomyelitis","volume":"30","author":"Giardino","year":"2004","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2018.07.005","article-title":"Calcitonin gene-related peptide decreases IL-1beta, IL-6 as well as Ym1, Arg1, CD163 expression in a brain tissue context-dependent manner while ameliorating experimental autoimmune encephalomyelitis","volume":"323","author":"Rossetti","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/HJH.0000000000001649","article-title":"Endogenous calcitonin gene-related peptide suppresses ischemic brain injuries and progression of cognitive decline","volume":"36","author":"Zhai","year":"2018","journal-title":"J. Hypertens."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0278-5846(01)00219-6","article-title":"Calcitonin gene-related peptide and calcitonin in the CSF of patients with dementia and depression: Possible disease markers","volume":"26","author":"Agren","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_26","first-page":"138","article-title":"Increased concentration of calcitonin gene-related peptide in cere-brospinal fluid of depressed patients","volume":"182","author":"Theodorsson","year":"1994","journal-title":"A possible trait marker of major depressive disorder. Neurosci. Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/brain\/110.6.1647","article-title":"The Presence of Calcitonin Gene-Related Peptide in Human Cerebrospinal Fluid","volume":"110","author":"Wimalawansa","year":"1987","journal-title":"Brain"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"108017","DOI":"10.1016\/j.neuropharm.2020.108017","article-title":"Characterization of the effects of calcitonin gene-related peptide receptor antagonist for Alzheimer\u2019s disease","volume":"168","author":"Na","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of pa-tients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s10072-011-0641-1","article-title":"Non-verbal memory measured by Rey\u2013Osterrieth Complex Figure B: Normative data","volume":"32","author":"Luzzi","year":"2011","journal-title":"Neurol. Sci."},{"key":"ref_34","unstructured":"Raven, J. (1958). Guide to Using the Coloured Progressive Matrices, HK Lewis & Co."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0447.1979.tb00264.x","article-title":"Validity of some neuropsychological tests in the assessment of mental de-terioration","volume":"60","author":"Caltagirone","year":"1979","journal-title":"Acta Psychiatr Scand."},{"key":"ref_36","unstructured":"(1987). Italian standardization and classification of Neuropsychological tests. The Italian Group on the Neuropsychological Study of Aging. Ital. J. Neurol Sci., 8, 1\u2013120."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/arclin\/10.6.511","article-title":"Poppelreuter-Ghent\u2019s overlapping figures test: Its sensitivity to age, and its clinical use","volume":"10","author":"Sala","year":"1995","journal-title":"Arch. Clin. Neuropsychol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/brain\/awz144","article-title":"Assessment of lesions on magnetic resonance imaging in multiple sclerosis: Practical guidelines","volume":"142","author":"Filippi","year":"2019","journal-title":"Brain"},{"key":"ref_39","first-page":"1","article-title":"Decision tree supports the interpretation of CSF biomarkers in Alzheimer\u2019s disease","volume":"11","author":"Mofrad","year":"2018","journal-title":"Alzheimer\u2019s Dementia: Diagn. Assess. Dis. Monit."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1097\/00001756-199812210-00028","article-title":"Severe pathological changes of parabrachial nucleus in Alzheimer\u02bcs disease","volume":"9","author":"Parvizi","year":"1998","journal-title":"NeuroReport"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2174\/1567205013666160606100509","article-title":"The Brainstem Tau Cytoskeletal Pathology of Alzheimer\u2019s Disease: A Brief Historical Overview and Description of its Anatomical Distribution Pattern, Evolutional Features, Pathogenetic and Clinical Relevance","volume":"13","author":"Rueb","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0006-8993(93)91320-R","article-title":"The cortical topography of temporal lobe hypometabolism in early Alz-heimer\u2019s disease","volume":"629","author":"Jagust","year":"1993","journal-title":"Brain Res."},{"key":"ref_43","first-page":"3","article-title":"Update on the pharmacology of calcitonin\/CGRP family of peptides: IUPHAR Review 25","volume":"175","author":"Hay","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/JAD-160677","article-title":"Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer\u2019s Disease Mouse Model","volume":"56","author":"Wang","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.bjp.0705337","article-title":"Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells","volume":"139","author":"Giniatullin","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"ref_46","first-page":"100","article-title":"Alpha-7 Nicotinic Receptors in Nervous System Disorders: From Function to Therapeutic Perspectives","volume":"17","author":"Bernardini","year":"2017","journal-title":"Central Nerv. Syst. Agents Med. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Siniavin, A.E., Streltsova, M.A., Kudryavtsev, D.S., Shelukhina, I.V., Utkin, Y.N., and Tsetlin, V.I. (2020). Activation of \u03b17 Nicotinic Acetylcholine Receptor Upregulates HLA-DR and Macrophage Receptors: Potential Role in Adaptive Immunity and in Preventing Immunosuppression. Biomolecules, 10.","DOI":"10.3390\/biom10040507"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fpsyt.2017.00102","article-title":"Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson\u2019s Disease with Comorbid Depression versus Patients with Major Depressive Disorder","volume":"8","author":"Svenningsson","year":"2017","journal-title":"Front. Psychiatry"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"a028936","DOI":"10.1101\/cshperspect.a028936","article-title":"Multiple Sclerosis Pathology","volume":"8","author":"Lassmann","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/2\/199\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:06:52Z","timestamp":1760134012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/2\/199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["biom12020199"],"URL":"https:\/\/doi.org\/10.3390\/biom12020199","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]}}}